Novavax, Inc.

NASDAQ:NVAX   4:00:00 PM EDT
16.49
-0.34 (-2.02%)
7:59:54 PM EDT: $16.75 +0.26 (+1.58%)
Business Deals

Mabion Extends Cooperation With Novavax

Published: 11/23/2022 15:37 GMT
Novavax, Inc. (NVAX) - Extends Cooperation With Novavax.
Under Extension Company to Analyse Peptide Mapping for Active Substance and Finished Product of Rs Sars-cov-2 Protein Sample.
First Stage of Work Will Be Implementation of Peptide Mapping Method.
Remuneration for First Stage of Contract at Over $0.5 Million.
Total Value of Statement of Work #9 Will Depend on Next Stage of Order.company to Also Carry Out Regular Analysis of Contracted Samples, Resulting in Issuing Appropriate Certificate.